TEVA-SUNITINIB

Identification of Teva-Sunitinib

No description

Google image searchProduct monograph

Active ingredient

sunitinib (sunitinib malate), 50 MG

DIN: 02526220

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 11-SEP-2023

ATC:

Reference brand drug: Sutent

Search on Google

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-sunitinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.